UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$278M |
| 2 |
United Rentals
URI
|
+$213M |
| 3 |
Affiliated Managers Group
AMG
|
+$189M |
| 4 |
Yelp
YELP
|
+$146M |
| 5 |
Microsoft
MSFT
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$223M |
| 2 |
RTX Corp
RTX
|
+$188M |
| 3 |
AGN
Allergan Inc
AGN
|
+$184M |
| 4 |
Crown Castle
CCI
|
+$171M |
| 5 |
Mastercard
MA
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.34% |
| 2 | Technology | 14.73% |
| 3 | Financials | 14.56% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RFMD
676
DELISTED
RF MICRO DEVICES INC
RFMD
| $19.3M | 0.02% |
1,161,246
+360,155
| +45% | +$4.81M |
|
|
MDR
677
DELISTED
McDermott International
MDR
| $19.3M | 0.02% |
2,206,076
+281,778
| +15% | +$3.16M |
|
678
Deluxe
DLX
$1.22B
| $19.2M | 0.02% |
308,598
-27,400
| -8% | -$1.61M |
|
|
ICPT
679
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $19.1M | 0.02% |
122,425
+29,300
| +31% | +$5.41M |
|
|
AUY
680
DELISTED
Yamana Gold, Inc.
AUY
| $19M | 0.02% |
4,689,123
-190,731
| -4% | -$864K |
|
|
IHS
681
DELISTED
IHS INC CL-A COM STK
IHS
| $19M | 0.02% |
166,471
-72,215
| -30% | -$8.96M |
|
682
Community Health Systems
CYH
$426M
| $18.9M | 0.02% |
424,443
+285,798
| +206% | +$12.2M |
|
683
Jazz Pharmaceuticals
JAZZ
$16.3B
| $18.8M | 0.02% |
115,062
+20,957
| +22% | +$3.48M |
|
684
Arrow Electronics
ARW
$11.5B
| $18.8M | 0.02% |
325,005
-3,769
| -1% | -$210K |
|
|
VRNT
685
DELISTED
Verint Systems
VRNT
| $18.7M | 0.02% |
629,726
-161,359
| -20% | -$4.7M |
|
686
Mettler-Toledo International
MTD
$28.5B
| $18.6M | 0.02% |
61,596
+3,709
| +6% | +$1.02M |
|
687
Avnet
AVT
$7.56B
| $18.5M | 0.02% |
430,512
-2,535
| -0.6% | -$107K |
|
688
Agios Pharmaceuticals
AGIO
$1.89B
| $18.4M | 0.02% |
164,500
+26,700
| +19% | +$2.38M |
|
689
ResMed
RMD
$32.3B
| $18.4M | 0.02% |
327,447
+9,997
| +3% | +$522K |
|
|
WLL
690
DELISTED
Whiting Petroleum Corporation
WLL
| $18.3M | 0.02% |
1,854
+421
| +29% | +$6.43M |
|
691
Vanguard FTSE Developed Markets ETF
VEA
$235B
| $18.2M | 0.02% |
480,048
+379,309
| +377% | +$14.7M |
|
692
Cooper Companies
COO
$14.5B
| $18M | 0.02% |
443,844
-2,983,552
| -87% | -$120M |
|
693
WEX
WEX
$6.44B
| $18M | 0.02% |
181,505
-6,294
| -3% | -$670K |
|
694
Snap-on
SNA
$21.6B
| $17.9M | 0.02% |
131,031
+53,431
| +69% | +$7M |
|
|
FL
695
DELISTED
Foot Locker
FL
| $17.9M | 0.02% |
318,489
+32,667
| +11% | +$1.81M |
|
696
Herbalife
HLF
$1.31B
| $17.9M | 0.02% |
947,794
-168,126
| -15% | -$3.6M |
|
697
Crown Holdings
CCK
$13.3B
| $17.8M | 0.02% |
348,960
+822
| +0.2% | +$39.6K |
|
698
Warner Bros
WBD
$64.6B
| $17.5M | 0.02% |
509,255
+275
| +0.1% | +$9.53K |
|
699
CubeSmart
CUBE
$9.46B
| $17.5M | 0.02% |
794,398
-7,600
| -0.9% | -$158K |
|
700
T-Mobile US
TMUS
$185B
| $17.5M | 0.02% |
649,623
-3,449
| -0.5% | -$95.3K |
|
Similar funds
UBS AM's Q4 2014 Portfolio in Review
As of Q4 2014, UBS AM held 2,689 positions worth $105B, up 4.2% from $101B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2014 filing shows 129 new, 1,370 increased, 628 reduced and 77 closed positions. Its largest new stake was Restaurant Brands International: 383,271 shares worth $15.1M. The largest sale was Biogen, an estimated $223M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q4 2014 buy was Restaurant Brands International: 383,271 shares worth $15.1M.
- UBS AM added most to Celgene Corp in Q4 2014, an estimated $278M increase.
- UBS AM's biggest Q4 2014 reduction was Biogen, cutting an estimated $223M.
- UBS AM fully exited KINDER MORGAN MANAGEMENT LLC in Q4 2014, selling an estimated $45.3M.
- UBS AM's ten largest holdings make up 14% of its $105B portfolio in Q4 2014.
- UBS AM opened 129 new positions and closed 77 in Q4 2014.
- UBS AM's portfolio value rose 4.2% quarter-over-quarter to $105B.
Based on UBS AM's 13F filing for Q4 2014, filed 2 Feb 2015.